The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
Clinical trial NCT03414658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03414658
- Sponsor
- Adrienne G. Waks
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2023-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.